Axq Capital, LP Prothena Corp Public LTD CO Transaction History
Axq Capital, LP
- $417 Billion
- Q1 2024
A detailed history of Axq Capital, LP transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Axq Capital, LP holds 13,416 shares of PRTA stock, worth $316,349. This represents 0.08% of its overall portfolio holdings.
Number of Shares
13,416
Previous 7,020
91.11%
Holding current value
$316,349
Previous $255 Million
30.26%
% of portfolio
0.08%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding PRTA
# of Institutions
187Shares Held
45.4MCall Options Held
119KPut Options Held
144K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$273 Million8.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.2MShares$99.1 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.75MShares$88.5 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.72MShares$87.7 Million0.0% of portfolio
-
State Street Corp Boston, MA3.47MShares$81.9 Million0.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $1.11B
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...